These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16730227)

  • 1. Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy.
    Zimmermann O; Kochs M; Zwaka TP; Bienek-Ziolkowski M; Höher M; Hombach V; Torzewski J
    Eur J Heart Fail; 2007 Jan; 9(1):51-4. PubMed ID: 16730227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial tumor necrosis factor-alpha expression in a sudden death due to dilated cardiomyopathy with endomyoelastofibrosis.
    Riezzo I; Pomara C; Neri M; Turillazzi E; Fineschi V
    Int J Cardiol; 2009 May; 134(2):e62-5. PubMed ID: 18372057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.
    Zwaka TP; Manolov D; Ozdemir C; Marx N; Kaya Z; Kochs M; Höher M; Hombach V; Torzewski J
    Am J Pathol; 2002 Aug; 161(2):449-57. PubMed ID: 12163370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
    Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
    Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies.
    Buzás K; Megyeri K; Hõgye M; Csanády M; Bogáts G; Mándi Y
    Eur Cytokine Netw; 2004; 15(1):53-9. PubMed ID: 15217753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Akatsu T; Shimoda Y; Segawa I; Hiramori K
    Eur J Heart Fail; 2005 Aug; 7(5):748-54. PubMed ID: 16087131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium.
    D'Ascia C; Cittadini A; Monti MG; Riccio G; Saccà L
    Eur Heart J; 2006 Jan; 27(2):201-6. PubMed ID: 16291773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: correlation to myocardial inflammatory activity.
    Sigusch HH; Lehmann MH; Schnittler U; Reinhardt D; Figulla HR
    Cytokine; 2000 Aug; 12(8):1261-6. PubMed ID: 10930309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy.
    Schoppet M; Ruppert V; Hofbauer LC; Henser S; Al-Fakhri N; Christ M; Pankuweit S; Maisch B
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1745-50. PubMed ID: 16288714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy.
    Högye M; Mándi Y; Csanády M; Sepp R; Buzás K
    Am J Cardiol; 2004 Jul; 94(2):249-51. PubMed ID: 15246916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy].
    Kuhn H; Lawrenz T; Beer G
    Med Klin (Munich); 2005 Sep; 100(9):553-61. PubMed ID: 16170644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C; Wittchen F; Suckau L; Witt H; Noutsias M; Fechner H; Schultheiss HP; Poller W
    Eur Heart J; 2008 May; 29(9):1168-80. PubMed ID: 18390538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
    Tentolouris C; Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Trikas A; Toutouzas P; Stefanadis C
    Int J Cardiol; 2004 Apr; 94(2-3):301-5. PubMed ID: 15093997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
    Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy.
    Zimmermann O; Kochs M; Zwaka TP; Kaya Z; Lepper PM; Bienek-Ziolkowski M; Hoher M; Hombach V; Torzewski J
    Int J Cardiol; 2005 Sep; 104(1):92-100. PubMed ID: 16137516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy.
    Mocelin AO; Issa VS; Bacal F; Guimarães GV; Cunha E; Bocchi EA
    Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial noradrenaline content: a factor not considered up to now for the prognosis of patients with dilated cardiomyopathy].
    Schofer J; Tews A; Rühwedel H; Reimitz PE; Mathey DG
    Z Kardiol; 1989 Jun; 78(6):366-71. PubMed ID: 2756732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients.
    Wallace CK; Stetson SJ; Küçüker SA; Becker KA; Farmer JA; McRee SC; Koerner MM; Noon GP; Torre-Amione G
    J Heart Lung Transplant; 2005 Jan; 24(1):46-51. PubMed ID: 15653378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of pathological parameters of endomyocardial biopsy in clinical outcome of patients of dilated cardiomyopathy--II. Value of cardiac immune complexes and heart reactive antibodies.
    Dawson L; Talwar KK; Chopra P
    Indian Heart J; 1991; 43(6):421-5. PubMed ID: 1823888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy.
    Vanderheyden M; Paulus WJ; Voss M; Knuefermann P; Sivasubramanian N; Mann D; Baumgarten G
    Heart; 2005 Jul; 91(7):926-31. PubMed ID: 15958363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.